DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 102 participants.
Also called NCT03633890
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 102 participants
- Sponsor
- Registry
-
NCT03633890
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03633890. Randomized; double masking; primary purpose treatment. Start 2018-08 (anticipated); primary completion 2019-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- DaZhu Rhodiola Rosea Capsule
- Intervention (Drug)
- DaZhu Rhodiola Rosea Simulation Capsule
- Lead sponsor
- Beijing Anzhen Hospital
- Collaborator
- Jiangsu Kangyuan Pharmaceutical Co. Ltd
Record details
- Record id
cardio:ct-nct03633890- Content hash
97ead849aef84c102c65a5d7976a197f9723e58a9ac83d6fd5fab89d45014f9d